Lab on a chip-based hepatic sinusoidal system simulator for optimal primary hepatocyte culture

Primary hepatocyte cultures are widely used in liver-related studies, including disease modeling and drug testing. However, these cells tend to lose their liver-specific functions quickly in traditional static culture systems. This decline limits their utility for long-term experiments and accurate physiological modeling. Existing methods struggle to maintain the metabolic and structural integrity of hepatocytes over time. Some studies have explored the role of flow in preserving liver cell function, but most require complex setups with external equipment. A portable and self-contained system that supports hepatocyte function without bulky infrastructure remains a challenge. The need for a scalable and efficient in vitro model that mimics the liver's natural environment is evident. This gap motivated the development of a microfluidic platform that can sustain hepatocyte function over extended periods. The proposed solution aims to bridge the limitations of current static cultures by integrating flow into a compact system.

The goal of this research was to create a microfluidic device that supports long-term hepatocyte function without the need for external power or large equipment. The study aimed to determine whether flow conditions could enhance the maintenance of liver-specific characteristics in hepatocytes. Traditional static cultures fail to sustain these features beyond a few days, which limits their application in drug testing and disease modeling. The researchers hypothesized that mimicking the liver's natural flow environment would improve cell viability and function. They focused on developing a chip-based system that could be used in standard laboratory settings. The study also sought to compare the performance of two different microfluidic designs. By evaluating albumin and urea production, the team aimed to assess the effectiveness of flow in maintaining hepatocyte function. The ultimate objective was to provide a reliable and scalable platform for in vitro liver studies.

The researchers designed a microfluidic chip that integrates flow without requiring external pumps or large devices. Two versions of the chip were tested: one with a monolayer structure and another with a concave chamber. These devices served as scaffolds for hepatocyte culture. The cells were cultured under both static and flow conditions for 13 days. Albumin and urea secretion levels were measured to evaluate liver function. Reverse transcription polymerase chain reaction (RT-PCR) was used to assess gene expression related to hepatocyte identity. The study compared two-dimensional and three-dimensional culture formats on the chips. Cell viability and functional performance were analyzed over time. The researchers did not use animal models or in vivo testing in this study. The focus was on optimizing the microfluidic design to support long-term hepatocyte cultures.

Cells cultured under flow conditions showed significantly higher albumin and urea secretion rates after 13 days compared to static cultures. RT-PCR results indicated that hepatocyte-specific genes were expressed at higher levels under flow conditions. The monolayer and concave chamber devices both supported improved function, with no significant difference between them. Three-dimensional cultures on the chips performed better than two-dimensional ones under flow. The flow system enhanced cell viability and metabolic activity over the 13-day period. These findings suggest that flow is a critical factor in maintaining hepatocyte function in vitro. The study demonstrated that the microfluidic chip can sustain liver-specific functions for extended periods. The results support the potential of this system for long-term and three-dimensional hepatocyte culture.

The study showed that flow conditions significantly improve the maintenance of hepatocyte function in vitro. The microfluidic chip supports long-term culture without the need for external equipment. Both two-dimensional and three-dimensional cultures benefited from flow, with three-dimensional showing better performance. The results suggest that flow is essential for preserving liver-specific gene expression and metabolic activity. The researchers propose that this system could be used for drug testing and disease modeling. The chip's compact design makes it suitable for standard laboratory use. The findings align with the hypothesis that mimicking the liver's natural flow environment enhances cell function. The study highlights the potential of microfluidic technology for advancing in vitro liver research.